{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-001715","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.335917+00:00","generated_at":"2026-06-04T07:49:12.448426+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Paysign FY2023 revenue up 24% to $47.3M; net income $6.5M; guides FY2024 revenue $54.5-56.7M","bullets":["Full-year 2023 total revenue $47.3M (+24% YoY); net income $6.5M ($0.12 diluted EPS) vs $1.0M ($0.02) in 2022.","Adjusted EBITDA $6.7M (+21% YoY); Q4 2023 revenue $13.7M (+29% YoY), net income $5.6M ($0.10 diluted EPS).","Plasma centers up 20 net to 464; pharma patient affordability programs up 24 net to 43; revenue from pharma patient affordability +172% YoY.","Exited FY2023 with $17.0M unrestricted cash, zero debt; repurchased 394,558 shares for $1.1M.","FY2024 guidance: revenue $54.5-56.7M, net income $2-3M ($0.04-0.06 diluted EPS), adjusted EBITDA $8-9M ($0.15-0.17 diluted EPS)."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-001715","json":"https://secwatch.observer/filing/0001683168-24-001715.json","markdown":"https://secwatch.observer/filing/0001683168-24-001715.md","text":"https://secwatch.observer/filing/0001683168-24-001715.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824001715/0001683168-24-001715-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824001715/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:49:12.448426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0768f26dbeed7ceaf3e5951492a725f7f57661f9","claim":"Paysign, Inc. reported the fiscal year ended December 31, 2023 results: revenue $47.3 million, net income $6.5 million, EPS $0.12.","evidence_excerpt":"PRESS RELEASE Exhibit 99.1 Earnings Release Paysign, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results For the Full Year · Full-year 2023 total revenues of $47.3 million, up 24% from full-year 2022 · Full-year 2023 net income of $6.5 million, or diluted earnings per share of $0.12, versus net income of $1.0 million, or diluted earnings per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1496443/000168316824001715/0001683168-24-001715-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$47.3 million"},{"label":"Net income","value":"$6.5 million"},{"label":"EPS","value":"$0.12"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}